Molecular Immunopathogenesis of DHF/DSS

DHF/DSS 的分子免疫发病机制

• 批准号: 8329181
• 负责人: Alan L Rothman
• 金额: $ 38.26万
• 依托单位: UNIVERSITY OF RHODE ISLAND
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-03 至 2013-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8329181
• 关键词: Acute; Acute Disease; Adverse event; Anti-Inflammatory Agents; Anti-inflammatory; Antibodies; Avidity; B-Cell Activation; B-Lymphocytes; Cells; Clinical; Complex; Culicidae; Data; Data Analyses; Dendritic Cells; Dengue; Dengue Virus; Disease; Disease Marker; Epidemiology; Exposure to; Flavivirus Infections; Frequencies; Funding; Genetic Polymorphism; Genotype; Goals; Host Factor 1 Protein; Immune; Immune response; Immune system; Immunity; Immunization; Immunologics; In Vitro; Individual; Infection; Inflammatory; Kinetics; Laboratories; Lead; Memory; Memory B-Lymphocyte; Modeling; Molecular; Morbidity - disease rate; Natural Immunity; Outcome; Pathogenesis; Peripheral Blood Mononuclear Cell; Phenotype; Placebos; Plasma; Plasmablast; Play; Prevention; Prevention strategy; Production; Research; Serotyping; Severities; Severity of illness; Shock; Specificity; T cell response; T memory cell; T-Lymphocyte; Testing; Tumor Necrosis Factor-Beta; Vaccination; Vaccines; Viral; Virus; Virus Diseases; adaptive immunity; cytokine; human TNF protein; immunopathology; improved; in vivo; mortality; novel vaccines; programs; promoter; response; vaccine development